CHEK1 and cancer: Given that cancer cells may have increased proliferation and increased levels of replication stress, which makes them more sensitive to ATR or Chk1 inhibitors [57, 58], we tested whether the propensity of different cell lines towards chromatid scattering correlates with elevated growth rate and elevated replication stress upon olaparib treatment.